A large genetic analysis suggests that the activity of certain genes could someday enable doctors to predict which lung cancer patients need more aggressive therapies and what not. But the findings also underscore the difficulty of conducting such predictions, especially in people who are in the earliest stages of the disease, when aggressive therapies...